Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ZYME · against 387 other Healthcare companies of similar size
Ranked #367 of 388 · scores higher than 5% of peers
Bars: peers in each 10-point band of the profitability score30 peers with a profitability score of 0–9, including ZYME · Click a bar to see the companies
Mainly because of its operating margin and return on assets, which are weaker than most Healthcare peers.
| Metric | ZYME | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 365 reported | Not reported | 6.1% | — | — | 33% |
| Operating marginHigher is better · 358 reported | -419.0% | 8.4% | 6% | 33% | |
| Return on assetsHigher is better · 372 reported | -37.8% | 2.1% | 8% | 33% | |
| Return on equityHigher is better · 357 reported | -72.3% | 5.2% | 9% | Context only | |
| Gross marginHigher is better · 402 reported | -246.7% | 48.8% | 0% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 321.5B INR (≈$3.9B) | 100 | 70 | |
| 1 | 174.8B INR (≈$2.1B) | 100 | 73 | |
| 1 | 97.3B INR (≈$1.2B) | 100 | 80 | |
| 5 | 12.3B CNY (≈$1.7B) | 99 | 85 | |
| 364 | 1.1B USD | 7 | 50 | |
| 364 | 2.4B USD | 7 | 20 | |
| 364 | 2.8B USD | 7 | 51 | |
| 367 | 1.5B USD | 6 | 30 | |
| 367 | 2.2B USD | 6 | 20 | |
| 369 | 1.7B USD | 5 | 33 | |
| 370 | 232.9B JPY (≈$1.6B) | 4 | 20 | |
| 370 | 1.9B USD | 4 | 49 | |
| 370 | 2.3B USD | 4 | 25 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score